Twenty-seven U.S. states have special rules blocking or restricting generic substitution for narrow therapeutic index drugs like warfarin and levothyroxine. Learn which states restrict swaps, why they exist, and how they affect patients and pharmacies.
Read More
Pharmacists verify generic equivalence using the FDA's Orange Book to ensure generics are therapeutically equivalent to brand-name drugs. This process relies on pharmaceutical and bioequivalence data, legal standards, and strict substitution rules to keep patients safe and costs low.
Read More
Real provider experiences with generic medications reveal that while most generics work just as well as brand-name drugs, patient trust, state regulations, and formulation differences can impact outcomes - especially for narrow therapeutic index drugs.
Read More
Pharmacokinetic studies are the primary method used to prove generic drugs work like brand-name versions, but they’re not foolproof. Learn how they work, where they fall short, and what’s changing in drug approval.
Read More